共 100 条
[1]
Bramson H. N.(2001)Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis J. Med. Chem. 44 4339-4358
[2]
Corona J.(2002)Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis Cancer Lett. 183 53-60
[3]
Davis S. T.(2007) and Bioorg. Med. Chem. Lett. 17 5897-5901
[4]
Dickerson S. H.(2008)Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4 Bioorg. Med. Chem. 16 3118-3124
[5]
Edelstein M.(2009)N-phenethyl and N-naphthylmethyl isatins and analogues as Curr. Cancer Drug Targets 9 298-306
[6]
Frye S. V.(2006) cytotoxic agents J. Clin. Oncol. 24 16-24
[7]
Gampe R. T.(2005)Design of new drug molecules to be used in reversing multidrug resistance in cancer cells Acta Pharm. 55 27-46
[8]
Harris P. A.(2006)Activity of SU11248, a multi-targeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma Bioorg. Med. Chem. 14 7324-7332
[9]
Hassell A.(2008)Biological activities of isatin and its derivatives Semin. Diagn. Pathol. 25 245-261
[10]
Holmes W. D.(2006)Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles Bioorg. Med. Chem. 14 6475-6485